Hypercalcemia Market Is Expected to Showcase a Significant Growth by 2032 – DelveInsight | Key Companies – Fujirebio, AbbVie, Merck, Amgen, Mylan, Bayer, Pfizer, Cipla, DiaSorin, Novartis, and Others